Evidence map›Paper›PMID 28700665›Full record

ArticlePloS one2017

Solution conformations of Zika NS2B-NS3pro and its inhibition by natural products from edible plants.

Amrita Roy, Liangzhong Lim, Shagun Srivastava, Yimei Lu, Jianxing Song

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 49 papers.

0numbers the graph read from it
0cells of the map it votes in
49citing papers in PubMed
8.9field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

49 citing papers in PubMed, 96 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Review
  5. Article
  6. Paritaprevir as a pan-antiviral against different flaviviruses.Frontiers in molecular biosciences · 2025
    Article
  7. An Overview of Zika Virus and Zika Virus Induced Neuropathies.International journal of molecular sciences · 2024
    Review
  8. Article
  9. Review
  10. Article
  11. Article
  12. Review
  13. Article
  14. Article
  15. Article
  16. Natural products as Zika antivirals.Medicinal research reviews · 2022
    Review
  17. Article
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Amrita RoyDepartment of Biological Sciences, Faculty of Science, National University of Singapore, Singapore, Singapore.
Liangzhong LimDepartment of Biological Sciences, Faculty of Science, National University of Singapore, Singapore, Singapore.
Shagun SrivastavaDepartment of Biological Sciences, Faculty of Science, National University of Singapore, Singapore, Singapore.
Yimei LuDepartment of Biological Sciences, Faculty of Science, National University of Singapore, Singapore, Singapore.
Jianxing SongDepartment of Biological Sciences, Faculty of Science, National University of Singapore, Singapore, Singapore.ORCID http://orcid.org/0000-0003-0224-6322
National University of Singapore · SG

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The recent Zika viral (ZIKV) epidemic has been associated with severe neurological pathologies such as neonatal microcephaly and Guillain-Barre syndrome but unfortunately no vaccine or medication is effectively available yet. Zika NS2B-NS3pro is essential for the proteolysis of the viral polyprotein and thereby viral replication. Thus NS2B-NS3pro represents an attractive target for anti-Zika drug discovery/design. Here, we have characterized the solution conformations and catalytic parameters of both linked and unlinked Zika NS2B-NS3pro complexes and found that the unlinked complex manifested well-dispersed NMR spectra. Subsequently with selective isotope-labeling using NMR spectroscopy, we demonstrated that C-terminal residues (R73-K100) of NS2B is highly disordered without any stable tertiary and secondary structures in the Zika NS2B-NS3pro complex in the free state. Upon binding to the well-characterized serine protease inhibitor, bovine pancreatic trypsin inhibitor (BPTI), only the extreme C-terminal residues (L86-K100) remain disordered. Additionally, we have identified five flavonoids and one natural phenol rich in edible plants including fruits and vegetables, which inhibit Zika NS2B-NS3pro in a non-competitive mode, with Ki ranging from 770 nM for Myricetin to 34.02 μM for Apigenin. Molecular docking showed that they all bind to a pocket on the back of the active site and their structure-activity relationship was elucidated. Our study provides valuable insights into the solution conformation of Zika NS2B-NS3pro and further deciphers its susceptibility towards allosteric inhibition by natural products. As these natural product inhibitors fundamentally differ from the currently-known active site inhibitors in terms of both inhibitory mode and chemical scaffold, our finding might open a new avenue for development of better allosteric inhibitors to fight ZIKV infection.

Indexed as

Binding SitesBiocatalysisBiological ProductsBiophysical PhenomenaBuffersCloning, MolecularDEAD-box RNA HelicasesHydrogen BondingKineticsModels, MolecularNucleoside-TriphosphatasePlants, EdibleProtein ConformationRNA HelicasesSerine EndopeptidasesSolutionsBiological ProductsBuffersDEAD-box RNA HelicasesNS2B protein, flavivirusNS3 protein, flavivirusNucleoside-TriphosphataseRNA HelicasesSerine EndopeptidasesSolutionsViral Nonstructural ProteinsViral Proteases

Identifiers

PMID28700665
PMCPMC5503262
OpenAlexW2734554201

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.